ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR

December 2, 1977

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

Agents Not Indicated In Curative Setting.

August 8, 2008

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979